Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients

This is not the most recent version

Information

DOI:
https://doi.org/10.1002/14651858.CD006300.pub3Copy DOI
Database:
  1. Cochrane Database of Systematic Reviews
Version published:
  1. 12 December 2012see what's new
Type:
  1. Intervention
Stage:
  1. Review
Cochrane Editorial Group:
  1. Cochrane Childhood Cancer Group

Copyright:
  1. Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Article metrics

Altmetric:

Cited by:

Cited 0 times via Crossref Cited-by Linking

Collapse

Authors

  • Renée L Mulder

    Correspondence to: Department of Paediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, Netherlands

    [email protected]

  • Marios Paulides

    Drug Commission of the German Medical Association, Berlin, Germany

  • Thorsten Langer

    Pediatrics, University Hospital for Children and Adolescents, Erlangen, Germany

  • Leontien CM Kremer

    Department of Paediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, Netherlands

  • Elvira C van Dalen

    Department of Paediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, Netherlands

Contributions of authors

Renée L Mulder identified studies meeting the inclusion criteria. She searched for unpublished and ongoing studies. She contributed to the interpretation of the results. She wrote and revised the review.

Marios Paulides designed the study and wrote the protocol. He identified studies meeting the inclusion criteria. He contributed to the interpretation of the results. He critically reviewed the review.

Wolfgang Stöhr critically reviewed the protocol. He contributed to the interpretation of the results. He critically reviewed the review.

Thorsten Langer critically reviewed the protocol. He contributed to the interpretation of the results. He critically reviewed the review.

Leontien CM Kremer designed the study and critically reviewed the protocol. She contributed to the interpretation of the results. She critically reviewed the review.

Elvira C van Dalen designed the study and wrote the protocol. She developed the search strategy. She identified the studies meeting the inclusion criteria. She searched for unpublished and ongoing studies. She interpreted the results. She wrote and revised the review.

All authors approved the final version.

Sources of support

Internal sources

  • No sources of support supplied

External sources

  • Foundation of Pediatric Cancer Research (SKK) Amsterdam, Netherlands.

  • Stichting Kinderen Kankervrij (KIKA), Netherlands.

Declarations of interest

None known.

Acknowledgements

Leontien Kremer, the Co‐ordinating Editor of the Childhood Cancer Group, is a co‐author of this review and therefore she could not act as the Co‐ordinating Editor for this review. Prof. Dr. Huib Caron (Department of Paediatric Oncology of the Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands) was willing to take on this task, for which we would like to thank him. Also, we would like to thank Edith Leclercq, the Trials Search Co‐ordinator of the Childhood Cancer Group, for running the search strategy in the different databases and providing us with the titles and abstracts of the searches and Wolfgang Stöhr for his help in preparing the protocol for this review. The editorial base of the Cochrane Childhood Cancer Group is funded by Kinderen Kankervrij (KIKA).

Version history

Published

Title

Stage

Authors

Version

2015 Sep 30

Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients

Review

Renée L Mulder, Marios Paulides, Thorsten Langer, Leontien CM Kremer, Elvira C van Dalen

https://doi.org/10.1002/14651858.CD006300.pub4

2012 Dec 12

Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients

Review

Renée L Mulder, Marios Paulides, Thorsten Langer, Leontien CM Kremer, Elvira C van Dalen

https://doi.org/10.1002/14651858.CD006300.pub3

2010 Feb 17

Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients

Review

Renée L Mulder, Marios Paulides, Thorsten Langer, Leontien CM Kremer, Elvira C van Dalen

https://doi.org/10.1002/14651858.CD006300.pub2

2006 Oct 18

Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients

Protocol

Renée L Mulder, Marios Paulides, Thorsten Langer, Leontien CM Kremer, Elvira C van Dalen

https://doi.org/10.1002/14651858.CD006300

PICOs

Population
Intervention
Comparison
Outcome

The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.

See more on using PICO in the Cochrane Handbook.